Pharma Company Disclosures

The companies below disclose financial relationships with physicians, and sometimes other health providers. Some of these companies (or one of their subsidiaries) are required to disclose under corporate integrity agreements with the Inspector General of the U.S. Dept. of Health and Human Services. Beginning in 2014, under the Physician Payment Sunshine Act, every pharmaceutical and medical device company will be required to report this information to the federal government.

Notes:

• Allergan first reported payments in 2010 but removed early payments from its website. Those payments are not included in this database. Allergan also reports in ranges and does not break out specific spending on each category.
• Lilly combines business travel and educational items/gifts in one category and does not break apart the value of each. Merck combines travel, meals and royalties into one category and does not break apart the value of each.
• AbbVie combines all categories into a single amount and does not break out specific spending on each category.
• UCB combines all categories into a single amount and does not break out specific spending on each category.
• Johnson & Johnson's report includes the payments disclosed separately by four of its subsidiaries. They release information on different schedules.
• * GlaxoSmithKline and Merck began disclosing voluntarily in 2009 but later agreed to do so as a condition of a legal settlement with the U.S. government.